Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ControlRad Systems

Explore full profile

A medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures for patients and…

Norcross, United StatesFounded 2011Biotech & Life Sciences
Valuation $50–100M Last recorded · 2019
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for ControlRad Systems and the history behind them.

About ControlRad Systems

ControlRad is a medical technology company focused on reducing radiation exposure during fluoroscopically guided procedures. The company serves healthcare providers, including hospitals and clinics, that perform these procedures, which are essential for diagnosing and treating various medical conditions. Operating in the medical device market, ControlRad's core product, ControlRad Trace, is an FDA-cleared technology designed to minimize radiation risks for both patients and medical staff. The business model is based on selling and licensing its technology to healthcare institutions, generating revenue through product sales and ongoing service agreements. ControlRad addresses a critical need in the medical field by offering a solution that enhances safety without compromising the quality of care.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2011
Headquarters
Norcross, United States
Employees
28
Open positions
None listed
Dealroom signal
57.5/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Risk Management, Biotechnology, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b
Links
WebsiteX

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Sep 2020 — — Windham Venture Partners · Questa Capital Management —
SERIES B✓Equity / VC Oct 2019 $15M $60M Questa Capital Management —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

ControlRad Systems website traffic

Latest recorded traffic for ControlRad Systems is 320 monthly website visits, down 43.9% over the last three months. ControlRad Systems's team grew 0% over the past year.

Latest monthly visits320 3-month web change-43.9% 1-year team growth0%
Monthly website visitsOct 2017–Dec 2023
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Sadra MedicalFocused on developing minimal invasive alternatives to surgical valve replacement and improve patient care Campbell, United States Acquired 10 $62M $193M
InviziusCoating solution reducing inflammatory complications in hemodialysis Chapelhall, United Kingdom Operational
AnvajoA Dresden-based technology company that develops, manufactures and sells innovative solutions for the analysis of liquids Dresden, Germany Operational
EndoSpanPre-clinical stage medical device startup developing a system for endovascular aortic aneurysm repair Herzliya, Israel Acquired
Vyv TechAntimicrobial LED technology that creates an inhospitable environment for bacteria & microbe growth in residential and commercial spaces Town of Colonie, United States Operational
FluoroPharmaMolecular imaging agents for positron emission tomography, enabling detection and assessment of pathology Boston, United States Operational
Suros Surgical SystemsIndiana-based medical device manufacturer company Indianapolis, United States Acquired
OptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management Oxford, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Questa Capital Management

Series B and later1 investor entered at this stage

  • Windham Venture Partners

Other known investors2 additional known investors

  • Baker & Eastlack Ventures
  • Rapha Capital Management

Talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Norcross HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ControlRad Systems on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ControlRad Systems’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.